FIGURE 2.

Construction and validation of the ALPS in the three groups. A, Distribution of BRCA patients and Survival status of BRCA patients with different risk scores, and Heatmap of the lncRNA signature in the training group. B, Distribution of BRCA patients and Survival status of BRCA patients with different risk scores, and Heatmap of the lncRNA signature in the testing group. C, Distribution of BRCA patients and Survival status of BRCA patients with different risk scores, and Heatmap of the lncRNA signature in the combined group